EARLY BUILD · 15 license-and-service checked provider listings · No patient data collected
Information and evidence context

IV therapy: product and safety questions

Understand ingredient, infection-control and source limits before comparing IV clinics.

Original sources checked October 10, 2026 · Editorial source review, not independent medical review

An IV service listing describes a practice's own advertised service. It is not evidence that a wellness infusion produces a claimed detoxification, energy or anti-aging benefit.

CDC's injection-safety guidance applies across healthcare settings, including outpatient care. It identifies unsafe injection and infusion practices as preventable infection risks. A clinic website or active professional license does not independently verify its infection-control practices.

FDA's August 27, 2026 glutathione notice describes adverse-event reports after IV glutathione made using a dietary-supplement-grade ingredient. The notice concerns the identified ingredient and reports; it is not evidence that all infusions have the same contamination.

FDA also warns about food-grade NAD+ used in sterile compounding and reports reactions consistent with excessive endotoxin exposure. Ingredient grade and sterile preparation need separate attention from a clinic's marketing language.

Ask who evaluates and prescribes, who administers the treatment, what the exact ingredients and source are, and how risks, monitoring and emergency care are handled. We provide no infusion recipes, doses or administration instructions.

Browse related providers and clinics

Information, not medical advice. No dosing, purchase guidance or treatment endorsement. A clinician must assess your individual circumstances.